ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1613

Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort

Daniel Wendling1, Clément Prati2, Alain Saraux3, Anna Molto4, Thao Pham5, Maxime Dougados6 and Xavier Guillot7, 1Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 2Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France, 3Rheumatology, CHU Brest, Brest, France, 4Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 5Rheumatology Department, Aix-Marseille University, APHM, Marseille, France, 6Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, 7PEPITE EA 4267, Bourgogne-Franche-Comté university, Besançon, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Dactylitis is a particular feature shared across the several phenotypical forms of spondyloarthritis (SpA), part of the classification criteria. There are only few data available about impact of dactylitis in early stage of SpA, and factors associated with the presence/history of dactylitis.

Aim

To study, at baseline of the DESIR cohort the presence/history of dactylitis in an attempt to evaluate frequency of dactylitis in SpA and to look at the factors associated with presence of dactylitis.

Methods:

DESIR is a prospective observational cohort of patients with recent onset (less than 3 years) inflammatory back pain, beginning before 50 years, suggestive of axial SpA, All available factors in the database (clinical, biological, imaging and medico economic) were compared between patients with and without past or present dactylitis at baseline (for categorical variables : odds-ratio +/- 95% CI and chi-square/Fisher tests, for continuous variables : unpaired t-tests / Mann-Whitney) , by uni and then multivariate analysis(logistic regression). Significance: p less than 0.05.

Results:

At baseline, 708 patients were analyzed. 97 had a past history or a concomitant dactylitis [prevalence 13.7% (CI 95% : 11.6 – 16.2)]. Dactylitis occurred before axial symptoms in 41.3 % and before any other symptom in 14.1 % of the cases. By univariate analysis, dactylitis was significantly associated with history of arthritis, enthesitis, psoriasis, with elevated CRP and ESR, enthesitic and arthritis scores, BASDAI, ASDAS,BASFI, SF-36, HAQ, ASQoL, shorter disease duration, systemic and local steroids use, and with lower structural damage (sacro iliac, spine)

Table shows the result of the multivariate analysis.

item

OR

CI 95%

Arthritis history or presence

2.9

[11.2 – 30.9]

csDMARD use during the past 6 months

5.2

[2.9 – 9.1]

Calcaneal enthesitis history or presence

6.7

[3.0 – 14.7]

BASDAI > median

1.08

[1.05 – 1.11]

BASFI > median

1.04

[1.02 – 1.06]

SF36 phys <median

0.92

[0.87 – 0.97]

Systemic steroids during the past 6 months

5.49

[2.93 – 10.28]

Sacro iliac erosion (MRI central reading)

0.02

[0.004 – 0.13]

mSASSS (central reading )

0.37

[0.21 – 0.66]

Conclusion:

In the DESIR cohort of patients suspected for early SpA, history of dactylitis is present in 13.7 % of the cases at baseline. It is an early feature associated with peripheral involvement, and associated with more burden of the disease, more frequent use of DMARDs and steroids, but with less structural damage.


Disclosure: D. Wendling, None; C. Prati, None; A. Saraux, None; A. Molto, None; T. Pham, None; M. Dougados, None; X. Guillot, None.

To cite this abstract in AMA style:

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X. Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dactylitis-in-early-spondyloarthritis-baseline-data-from-a-prospective-french-national-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dactylitis-in-early-spondyloarthritis-baseline-data-from-a-prospective-french-national-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology